On May 20th 2009 the Champalimaud Foundation will host the inaugural Champalimaud Cancer Research Symposium in Lisbon, Portugal
Chair:
James D. Watson: Nobel laureate and co-discoverer of the structure of the DNA molecule
Confirmed speakers:
Paul Marks, Memorial Sloan-Kettering Cancer Center, USA
José Baselga, Vall d’Hebron Institute of Oncology, Spain
Maria Blasco, CNIO, Spain
Peter Jones, University of Southern California
Raghu Kalluri, Beth Israel Deaconess Medical Center, USA
Yoel Kloog, Tel Aviv University, Israel
Hedvig Hricak, Memorial Sloan-Kettering Cancer Center, USA
Giovanni Morrone, University of Catanzaro, Italy
Lee Nadler, Dana-Farber Cancer Institute, USA
Bruce Ponder, Cancer Research U.K.
Charles Sawyers, Memorial Sloan-Kettering Cancer Center, USA
Register online here
http://www.fchampalimaud.org/care-research/cancer-symposium-20091/form-registration/25 Euros (students)
Topics to include:
- Histone deacetylase inhibitors – from bench to bedside
- The role of genes in shaping our risk of disease : lessons from cancer
- New horizons in oncologic imaging
- Epigenetic therapy
- Design of the new Ras inhibitor Salirasib (FTS): From concept to mechanism of action and Phase I trials
- Turning stem cells bad: Dissection of Leukaemogenesis through gene transfer in human haematopoietic stem cells
- Novel Approaches to Anti-Androgen Therapy
- The Rate of Cancer Progression and Metastasis is Controlled by Tumor Microenvironment
Email:
cancer2009@fchampalimaud.org http://www.fchampalimaud.org/care-research/champalimaud-cancer-symposium-2009/about/RM
.
